Adma Biologics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (16)

Latest Posts

About This Stock More About This Stock
ADMA Biologics Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Saturday, June 9, 2018 2:00 AM EDT
ADMA Biologics, Inc. announced today the pricing of its previously announced underwritten public offering of 8,368,200 shares of its common stock at a public offering price of $4.78 per share.
In this article: ADMA
Read
ADMA Biologics: Almost Ready To Run Between The Toes Of Giants
Article By: Simon Daly
Tuesday, March 6, 2018 10:27 PM EDT
ADMA’s lead product candidate has positive data, positioned for high unmet medical need. The burden of lifting regulatory hold is lower than might be perceived by investors at present.
In this article: ADMA
Read
ADMA Biologics Announces Pricing Of Follow-On Offering
Article By: NASDAQ GlobeNewswire
Thursday, November 9, 2017 11:27 AM EDT
ADMA Biologics, Inc. today announced the pricing of an underwritten public offering of approximately 17.0 million shares of its common stock at a public offering price of $2.15 per share, representing gross proceeds of approximately $36.5 million.
In this article: ADMA
Read
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
Article By: The Life Sciences Report
Wednesday, March 9, 2016 5:47 PM EDT
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.
In this article: SGYP, CRMD, ORMP, SRNE, ARRY, PTIE, AGEN, GALE, PPHM, EVOK, ADMA, AKBA, KPTI, VSTM, AST, RXDX, AGTC, WVE, FATE, FLKS, PIRS, ABEO
Read
The 2016 Small-Cap Biotech Watchlist Debuts At The Biotech Showcase
Article By: The Life Sciences Report
Wednesday, January 27, 2016 6:16 PM EDT
This may prove a challenging year for small-cap biotechs, but the five analysts who selected companies for inclusion on The Life Sciences Report's 2016 Small-Cap Biotech Watchlist believe these companies have a good producing value for investors.
In this article: AZN, NVO, SGYP, SNY, CRMD, ORMP, CMXHY, SRNE, ALNY, ARRY, INCY, IRWD, PTIE, REGN, VRTX, AGEN, GALE, GRFS, PPHM, EVOK, ADMA, AKBA, VSTM, AST, RXDX, AGTC, NK, WVE, FATE, FLKS
Read

PARTNER HEADLINES

Latest Tweets for $ADMA

No tweets yet!